Expected to open in October 2021, this additional cleanroom more than doubles the Quattroflow cleanroom space in Duisburg, Germany. The investment will help support growing customer demand for single-use pump products used in the production of biologics, drugs and vaccines. The new cleanroom will operate independently from the existing one while following the same assembly procedures to achieve product uniformity.
“Single-use technologies are expanding rapidly in biopharma production thanks to the growing market of biopharmaceuticals,” said Karl Buscher, PSG President. “They also played a key role when manufacturers needed to quickly ramp up production of the COVID-19 vaccines. Therefore, expanding our cleanroom footprint is a critical step in increasing our single-use manufacturing capacity to satisfy this growing market demand. Additionally, this investment further strengthens our production reliability and capabilities, allowing us to ensure product consistency and safety.”
Available in a variety of sizes, Quattroflow single-use pumps are designed to provide fast installation and qualification of single-use manufacturing systems. They also reduce downtime between batches by eliminating the need for cleaning validation while increasing manufacturing efficiency and delivering the required levels of product purity and sterility biopharma applications demand.
